-
3961
-
3962
-
3963
-
3964
Physiologists as medical scientists: An early warning from the German academic system
Published 2024-11-01Get full text
Article -
3965
-
3966
-
3967
Designing a Conceptual model for Evaluating the Performance of Software Developers in Fintech Organizations
Published 2024-11-01Get full text
Article -
3968
-
3969
-
3970
-
3971
-
3972
Utilizing kombucha culture for coffee fermentation and biochemical characteristic analysis
Published 2025-01-01Get full text
Article -
3973
-
3974
-
3975
Exploring the Impact of Citric Acid on Mitigating Sweet Potato Soft Rot and Enhancing Postharvest Quality
Published 2025-01-01Get full text
Article -
3976
Ketamine Infusion as an Adjunct to Opioid Analgesia in Pediatric Patients with High-Risk Neuroblastoma Undergoing Treatment with Dinutuximab: Adverse Effects and Safety in a Non-IC...
Published 2025-01-01“…Keri A Streby,1,* Joseph D Tobias,2,3,* Evan McPhaden,4 Shannon Downie,4 Joseph Stanek,1 Catherine Roth,2 Priyal O Patel1,2 1Department of Pediatrics- Division of Pediatric Oncology, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, OH, USA; 2Department of Anesthesiology & Pain Medicine, Nationwide Children’s Hospital, Columbus, OH, USA; 3Department of Anesthesiology & Pain Medicine, The Ohio State University College of Medicine, Columbus, OH, USA; 4Ohio University Heritage College of Osteopathic Medicine, Dublin Campus and Ohio University, Athens, OH, USA*These authors contributed equally to this workCorrespondence: Priyal O Patel, DO Department of Anesthesiology & Pain Medicine Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, Ohio, 43205, USA, Tel +1-(614) 722-3728, Fax +1-(614) 722-4203, Email priyal.patel@nationwidechildrens.orgIntroduction: Anti-GD2 immunotherapy has improved outcomes for children with high-risk neuroblastoma (HRNBL). …”
Get full text
Article -
3977
-
3978
-
3979
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Get full text
Article -
3980